Vialwirebiotech, curated
August 16, 2026, 3:24 PM
August 10, 2026
- 12:00 PM · BioWorld12:00 PMTenax’s shares anything but ‘Level’ after failed phase III — BioWorld
- 12:00 PM · BioWorld12:00 PMBiomarin eyes Amicus synergy as it cuts Inozyme rare disease ERT — BioWorld
- 11:44 AM · Drug Discovery World11:44 AMBase editing to enable single-base genomic changes — Drug Discovery World
- 11:25 AM · BBC — Health11:25 AMNew weight loss pill approved for use in UK — BBC — Health
- 11:11 AM · STAT News
- 10:25 AM · BioPharma Dive10:25 AMScribe’s Benjamin Oakes on a rare IPO and bringing CRISPR to the masses — BioPharma Dive
- 10:15 AM · Drug Discovery World10:15 AMAscendis provides update on achondroplasia programmes — Drug Discovery World
- 9:00 AM · BioWorld9:00 AMAstronautx exercises option under Saniona neurology collaboration — BioWorld
- 9:00 AM · BioWorld9:00 AMCSPC announces IND approval for mpox mRNA vaccine SYS-6037 — BioWorld
- 9:00 AM · BioWorld9:00 AMPheast’s PHST-001 targets CD24 to boost antitumor immunity — BioWorld
- 9:00 AM · BioWorld9:00 AMOculis signs asset purchase agreement with Accure Therapeutics — BioWorld
- 8:03 AM · STAT News
- 7:14 AM · Pharmaceutical Technology7:14 AMSobi licenses Innate’s CTCL drug for up to $580m as it heads to Phase III — Pharmaceutical Technology
- 5:44 AM · Pharmaceutical Technology5:44 AMInnovent and Daiichi Sankyo sign deal for Vanflyta in China — Pharmaceutical Technology
- 4:41 AM · Pharmaceutical Technology4:41 AMEnergenesis and Taiwan Tanabe to develop ENERGI-F703DFU for DFUs — Pharmaceutical Technology
- 4:30 AM · STAT News
- 4:00 AM · Drug Discovery World4:00 AMNew therapy targets blocks to immunotherapy success in solid tumours — Drug Discovery World
August 9, 2026
- 7:16 PM · STAT News7:16 PMSTAT+: A shortage of two Sanofi medicines for Pompe disease rattles patients — STAT News